Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.85M Buy
23,514
+1,823
+8% +$210K 0.06% 131
2025
Q4
$2.3M Sell
21,691
-1,088
-5% -$102K 0.05% 148
2025
Q3
$1.93M Buy
22,779
+1,542
+7% +$127K 0.05% 168
2025
Q2
$1.74M Sell
21,237
-61
-0.3% -$4.85K 0.04% 171
2025
Q1
$1.93M Sell
21,298
-673
-3% -$62.8K 0.05% 144
2024
Q4
$2.17M Buy
21,971
+2,281
+12% +$235K 0.05% 142
2024
Q3
$2.25M Sell
19,690
-483
-2% -$57.4K 0.05% 146
2024
Q2
$2.51M Sell
20,173
-1,233
-6% -$159K 0.07% 127
2024
Q1
$2.84M Buy
21,406
+3,149
+17% +$388K 0.08% 120
2023
Q4
$2.15M Buy
+18,257
New +$1.9M 0.07% 131

Other funds holding MRK

AlTi Global's MRK Position: Q1 2026 in Review

AlTi Global increased its Merck (MRK) stake by 8.4% in Q1 2026, buying an estimated $210K and bringing the position to 23,514 shares worth $2.85M. The position accounts for 0.06% of the portfolio, ranked #131.

AlTi Global first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • AlTi Global held 23,514 shares of Merck worth $2.85M as of Q1 2026.
  • AlTi Global bought 1,823 Merck shares in Q1 2026, an estimated $210K.
  • Merck made up 0.06% of AlTi Global's portfolio in Q1 2026, its #131 holding.
  • AlTi Global first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on AlTi Global's 13F filing for Q1 2026, filed 7 May 2026.